未名医药 (002581.sz)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(未名医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 210,782,004.4683,804,783.29429,790,105.06338,346,310.25209,166,285.0175,602,502.59357,080,537.01275,529,090.79187,644,945.2387,387,093.61
 营业利润(元) -24,256,926.20-27,947,839.97-293,351,196.8044,625,168.95-50,456,579.84-21,146,063.0233,671,473.8772,610,190.7234,491,207.837,298,958.59
 利润总额(元) -23,319,213.24-26,847,045.89-313,249,951.4042,686,285.45-51,417,931.27-21,455,402.6612,724,656.9871,197,011.3833,792,998.317,309,635.05
 净利润(元) -24,814,640.42-27,055,340.81-322,135,112.2738,528,504.57-50,853,180.78-21,379,098.60-868,190.7968,063,937.3529,242,875.514,770,313.05
 归属于母公司股东的净利润(元) -29,614,917.07-27,704,081.15-332,458,291.4929,713,342.05-53,757,277.48-21,505,965.06-14,689,829.8564,450,385.3023,956,571.471,834,525.81
盈利能力:
 销售毛利率(%) 80.6580.1380.6081.1680.9480.7178.6676.7074.9268.13
 销售净利率(%) -11.77-32.28-74.9511.39-24.31-28.28-0.2424.7015.585.46
 净资产收益率(%) -1.36-1.26-14.971.22-2.27-0.91----
 总资产报酬率ROA(%) -0.96-1.08-11.781.76-1.67-0.67----
 投入资本回报率ROIC(%) -1.43-1.34-14.351.17-2.14-0.85-0.572.480.930.07
营运能力:
 存货周转率(次) 0.480.191.010.760.450.18----
 应收账款周转率(次) 1.350.652.861.971.080.41----
 总资产周转率(次) 0.080.030.170.120.080.03----
偿债能力:
 资产负债率(%) 5.114.566.9910.1011.9811.5013.6311.5110.4110.27
 股东权益比率(%) 90.0490.7588.5086.1984.4685.0683.0585.5386.4986.68
 已获利息倍数(倍) 30.0897.79-41.726.83-8.80-6.432.7414.2811.535.53
 流动比率 8.616.703.722.611.451.381.421.471.962.11
 速动比率 7.655.483.032.211.130.981.131.121.491.70
发展能力:
 营业收入增长率(%) 0.7710.8520.3622.8011.47-13.49-11.33-12.75-16.355.84
 营业利润增长率(%) 51.93-32.17-971.22-38.54-246.29-389.71-87.67-79.49-76.38-65.04
 税后利润增长率(%) 44.91-28.82-2,164.66-53.90-324.39-1,272.29-105.42-81.45-82.63-92.48
 净资产增长率(%) -12.01-12.96-13.29-1.63-3.73-1.59-0.61-0.496.9611.60
 总资产增长率(%) -17.46-18.41-18.57-2.39-1.410.283.683.158.0010.71

前瞻产业研究院